Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Multiply Labs raises $75M in Series B funding led by AstraZeneca Ventures, Lingotto, Legend Biotech and Strange Ventures to scale robotic drug manufacturing platform for cell and gene therapies.

PRIVATESep 17, 2026•about 4 hours ago

Amount Raised

$75 Million

Round Type

Series B

San FranciscoInformation Technology

Investors

Founders FundLux CapitalCasdin CapitalStrange VenturesLegend BiotechLingottoAstra Zeneca Ventures

Description

Multiply Labs raised $75 million in Series B funding to expand its robotic manufacturing platform for cell and gene therapies and advanced biologics. The round was led by AstraZeneca Ventures, Lingotto, Legend Biotech and Strange Ventures, with support from returning investors Casdin Capital, Lux Capital and Founders Fund. The capital will be used to expand manufacturing capacity, accelerate product development, and grow engineering, regulatory and commercial teams. Multiply Labs' robotic clusters can reduce cost per dose by 74% and deliver up to 100 times the throughput of manual manufacturing.

Company Information

Company

Multiply Labs, Inc.

Location

1040 MARIPOSA STREET

San Francisco, California, United States

About

Multiply Labs develops advanced robotic systems that manufacture individualized drugs at scale. Our products are enabled by the combination of pharmaceutical science with robotics technology. Multiply Labs has built and operates a unique robotic pharmaceutical manufacturing facility in San Francisco.

Don't miss Multiply Labs, Inc.'s next move

Get an email the moment Multiply Labs, Inc. raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contactsAlice M., Executive Officer
Predictive Intelligence
Strategic

ML-powered predictions for Multiply Labs, Inc.'s next move

See what Strategic adds

Funding Insights

Based on industry data
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Multiply Labs, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.